A SCID mouse-human lung xenograft model of SARS-CoV-2 infection
Wenkun Fu,Wei Wang,Lunzhi Yuan,Yanzhen Lin,Xiumin Huang,Rirong Chen,Minping Cai,Che Liu,Liqiang Chen,Ming Zhou,Kun Wu,Huan Zhao,Dequan Pan,Jian Ma,Junping Hong,Bingke Zhai,Yali Zhang,Zhibo Kong,Yingbin Wang,Yixin Chen,Quan Yuan,Huachen Zhu,Tong Cheng,Yi Guan,Ningshao Xia
DOI: https://doi.org/10.7150/thno.58321
IF: 11.6
2021-01-01
Theranostics
Abstract:SARS-CoV-2 infection, which is responsible for the current COVID-19 pandemic, can cause life-threatening pneumonia, respiratory failure and even death. Characterizing SARS-CoV-2 pathogenesis in primary human target cells and tissues is crucial for developing vaccines and therapeutics. However, given the limited access to clinical samples from COVID-19 patients, there is a pressing need for <i>in vitro/in vivo</i> models to investigate authentic SARS-CoV-2 infection in primary human lung cells or tissues with mature structures. The present study was designed to evaluate a humanized mouse model carrying human lung xenografts for SARS-CoV-2 infection <i>in vivo</i>. <b>Methods:</b> Human fetal lung tissue surgically grafted under the dorsal skin of SCID mice were assessed for growth and development after 8 weeks. Following SARS-CoV-2 inoculation into the differentiated lung xenografts, viral replication, cell-type tropism and histopathology of SARS-CoV-2 infection, and local cytokine/chemokine expression were determined over a 6-day period. The effect of IFN-α treatment against SARS-CoV-2 infection was tested in the lung xenografts. <b>Results:</b> Human lung xenografts expanded and developed mature structures closely resembling normal human lung. SARS-CoV-2 replicated and spread efficiently in the lung xenografts with the epithelial cells as the main target, caused severe lung damage, and induced a robust pro-inflammatory response. IFN-α treatment effectively inhibited SARS-CoV-2 replication in the lung xenografts. <b>Conclusions:</b> These data support the human lung xenograft mouse model as a useful and biological relevant tool that should facilitate studies on the pathogenesis of SARS-CoV-2 lung infection and the evaluation of potential antiviral therapies.
medicine, research & experimental